Department of Health and Human Services April 2007 – Federal Register Recent Federal Regulation Documents
Results 101 - 150 of 311
Advancing System Improvements to Support Targets for Healthy People 2010 (ASIST2010)
The DHHS Office on Women's Health (OWH) was established in 1991 to improve the health and well being of all women and girls in the United States (US). To achieve this long-term goal, the OWH focuses on reducing the health differences (disparities) between women and men, between girls and boys, and among populations of women by supporting programs such as the 48 Multidisciplinary Health Models for Women sites throughout the U.S. Each site has implemented its own paradigm and blend of services to fit the needs of its community. The National Centers of Excellence in Women's Health (CoEs), National Community Centers of Excellence in Women's Health (CCOEs), and the CoE- and CCOE- Ambassadors for Change (AFCs), in particular, have served as leaders and change agents in the area of women's health. Their pioneering efforts have led to changes in the way women's health services are delivered, changes in women's health curricula, acceptance of community health workers and allied health professionals as key members of the care delivery team, development of leadership and empowerment programs for women, and much more. These programs have also demonstrated that, on a local level, the formation of collaborative partnerships across schools, clinics, and disciplines within the academic community, and among community-based organizations with similar missions, leads to broader outreach, the delivery of more counseling and preventive services, improved access to more comprehensive services, and greater patient satisfaction. More information about these programs can be found at https://www.womenshealth.gov/owh/multidisciplinary/. A recent literature review commissioned by the OWH (Literature Review on Effective Sex- and Gender-Based Systems/Models of Care, 2007, also available at (https://www.womenshealth.gov/owh/multidisciplinary/ reports/GenderBasedMedicine/) to help guide the development of this RFA, reports that the comprehensive, integrated, multidisciplinary models of women's health care, first implemented by OWH about a decade ago, have helped to raise awareness of women's health issues and have helped to establish women's health as a discipline. A recommendation made was that it is time for OWH to move to a broader sex- and gender- based approach to health care, building on the success of its comprehensive, integrated, multidisciplinary models programs. The literature review addressed several broad questions and contains interesting and useful information on a variety of topics relevant to this RFA. The information on sex and gender \1\ differences in the current healthcare system, the effectiveness of sex- and gender-based healthcare practices, the effectiveness of a sex- and gender-based focus on clinical care, and the effectiveness of patient advocates/ navigators in getting men into the healthcare system and to needed care may be useful background information for applicants.
Meeting of the Advisory Committee on Blood Safety and Availability
As stipulated by the Federal Advisory Committee Act, the U.S. Department of Health and Human Services is hereby giving notice that the Advisory Committee on Blood Safety and Availability (ACBSA) will hold a meeting. The meeting will be open to the public on both Thursday, May 10 and Friday, May 11, 2007.
Memorandum of Understanding Between the National Cancer Institute and the Food and Drug Administration
The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between FDA and the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) of the Department of Health and Human Services (DHHS). The purpose of this MOU is to establish a formal collaboration between FDA and NCI regarding the creation of a common standards-based data repository to facilitate the electronic exchange and analysis of data from research studies on investigational drugs in a fully secure manner.
Medical Device User Fee and Modernization Act; Public Meeting
The Food and Drug Administration (FDA) is announcing a public meeting to discuss our proposed recommendations for the reauthorization of the Medical Device User Fee and Modernization Act of 2002 (MDUFMA I) for fiscal years (FY) 2008 through 2012, as well as other proposals to improve the review of medical devices and the third party inspection program. These proposed recommendations were developed after discussions with the regulated industry. Section 105 of MDUFMA I directs FDA to publish these proposed recommendations in the Federal Register, hold a meeting at which the public may present its views on the recommendations, and provide for a period of 30 days for the public to provide written comments on the recommendations. The public meeting and comment period will provide an opportunity for public input on the proposed recommendations from all interested parties, including the regulated industry, scientific and academic experts, healthcare professionals, and representatives of patient and consumer advocacy groups.
President's Council on Physical Fitness and Sports
As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (DHHS) is hereby giving notice that the President's Council on Physical Fitness and Sports will hold a meeting. This meeting is open to the public. A description of the Council's functions is included with this notice.
Nominations of Topics for Evidence-based Practice Centers
AHRQ invites nominations of topics for evidence reports, technology assessments, and comparative and effectiveness reviews conducted by its Evidence-based Practice Centers (EPC) Program relating to the prevention, diagnosis, treatment and management of common diseases and clinical conditions, as well as topics relating to the organization and financing of health care. Previous evidence reports and comparative effectiveness reviews can be found at https:// www.ahrq.gov/clinic/epcix.htm and https://effectivehealthcare.ahrq.gov/ products/progress.cfm, respectively.
Meeting of the Chronic Fatigue Syndrome Advisory Committee
As stipulated by the Federal Advisory Committee Act, the U.S. Department of Health and Human Services is hereby giving notice that the Chronic Fatigue Syndrome Advisory Committee (CFSAC) will hold a meeting. The meeting will be open to the public.
National Toxicology Program (NTP); Report on Carcinogens Review Process for the 12th Report on Carcinogens (RoC)
The NTP announces its scientific review process to review nominations for the 12th RoC. The process is available on the NTP Web site https://ntp.niehs.nih.gov (select ``Report on Carcinogens'') or by contacting Dr. C.W. Jameson at the address provided below.
Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.
National Institute of Environmental Health Sciences (NIEHS); Request for Public Comments on the Review of the Centers for Children's Environmental Health and Disease Prevention Program
As part of an effort to evaluate the NIEHS research portfolio of investigator-initiated research on children's environmental health, the NIEHS convened an independent panel to review the Centers for Children's Environmental Health and Disease Prevention Program (``Children's Centers'') in cooperation with the U.S. Environmental Protection Agency (EPA). The panel was convened as a working group to the NIEHS National Advisory Environmental Health Sciences Council (NAEHS). At this time, the NIEHS seeks public comment on the working group report for consideration by the NAEHS Council, the NIEHS, and EPA's Office of Research and Development (ORD) in evaluating the best approaches for future funding of children's environmental health research. The report is available at https://www.niehs.nih.gov/ conferences/od/cehr/report.htm.
Medicare Program; Revisions to Payment Policies, Five-Year Review of Work Relative Value Units, and Changes to the Practice Expense Methodology Under the Physician Fee Schedule, and Other Changes to Payment Under Part B; Correcting Amendment
This correcting amendment corrects several technical and typographical errors in the final rule with comment period that appeared in the December 1, 2006 Federal Register (71 FR 69624). The final rule with comment period addressed Medicare Part B payment policy, including the physician fee schedule (PFS) that is applicable for calendar year (CY) 2007; payment for covered outpatient drugs and biologicals; payment for renal dialysis services; and policies related to independent diagnostic testing facilities (IDTFs). The final rule with comment period also updated the list of certain services subject to the physician self-referral prohibitions.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
